• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.35% Nasdaq Down 0.81%

    Merrimack Pharmaceuticals, Inc. (MACK)

    -NasdaqGM
    4.87 Down 0.40(7.59%) Aug 24, 4:00PM EDT
    Prev Close:5.27
    Open:5.26
    Bid:4.95 x 3000
    Ask:5.40 x 1000
    1y Target Est:12.00
    Beta:2.67142
    Earnings Date:Nov 7 - Nov 11 (Est.)
    Day's Range:4.82 - 5.39
    52wk Range:4.82 - 11.00
    Volume:2,894,047
    Avg Vol (3m):1,859,110
    Market Cap:629.40M
    P/E (ttm):N/A
    EPS (ttm):-1.53
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for MACK

    Comparison

    Symbol% ChgMkt Cap
    MACKDown 7.59%629.40M
    THLDDown 11.74%61.22M
    IMMUDown 7.07%264.59M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):7.34
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.98
    Quarterly EPS Est (Sep-16) :-0.20
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):-0.94

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer primarily in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback